Fig. 3From: Relationships between developmental strategies for additional indications and price revisions for anticancer drugs in JapanKaplan-Meier curve for National Health Insurance price revisions by stratification of drug characteristics. Stratified by initial indication: Orphan or non-orphan cancer. P = 0.7682, log-rank test, Median time for an orphan cancer: 2695 days, Median time for a non-orphan cancer: 3051 daysBack to article page